Paul Blake's Net Worth
$932 Thousand
Who is Paul Blake?
Paul Blake does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include VIACELL INC, CV Sciences, Inc., CEPHALON INC, and MEMORY PHARMACEUTICALS CORP.
SEC CIK
Paul Blake's CIK is 0001209719
Past Insider Trading and Trends
2005 was Paul Blake's most active year for acquiring shares with 4 total transactions. Paul Blake's most active month to acquire stocks was the month of November. 2006 was Paul Blake's most active year for disposing of shares, totalling 5 transactions. Paul Blake's most active month to dispose stocks was the month of January. 2020 saw Paul Blake paying a total of $4,992.39 for 162,801 shares, this is the most they've acquired in one year. In 2006 Paul Blake cashed out on 6,938 shares for a total of $517,016.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
VIACELL INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 11
| |||
| No matching records found | |||||||||
CV Sciences, Inc. (CVSI) Snapshot price: $0.0448
InvestorPaul Blake owns 12,801 units of Common Stock which is worth $573.48. In the year 2019 Paul Blake acquired a total of 12,801 shares in CV Sciences, Inc. at a cost of $4,992.39.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
∞
| 12.8K |
$0.39 | $4,992.39 | 12.8K |
May 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CEPHALON INC No price found
Exec VP, Clin Res & Reg AffPaul Blake owns 40,000 units of Common Stock.acquired a total of 55,000 shares in CEPHALON INC, Paul also disposed a total of 15,000 shares of CEPHALON INC equalling to $936,250.59.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -14.78% | -6.94K |
$74.52 | -$517,016.00 | 40K |
Feb 17
| |||
Form 4
| -6.12% | -3.06K |
$56.59 | -$173,278.58 | 46.94K |
Dec 16 - Dec 19
| |||
Form 4
| +42.86% | 15K |
—
|
—
| 50K |
Dec 1
| |||
Form 4
| +75.00% | 15K |
$49.19 | -$245,956.01 | 35K |
Dec 16 - Dec 17
| |||
Form 4
|
∞
| 20K |
—
|
—
| 20K |
Dec 17
| |||
Form 4
| -100.00% | -202.00 |
$46.83 | -$9,459.66 |
0
|
Nov 26
| |||
| No matching records found | |||||||||
MEMORY PHARMACEUTICALS CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||